Aorto Femoral Bypass Graft in Chronic Limb Ischemia Patient

Authors

R. Muhammad Budiarto, MD
drbudiarto123@gmail.com
Departement of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga
M. Rifqi D. Hasan Departement of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga

Vol. 2 No. 1 (2021): Cardiovascular and Cardiometabolic Journal

Case Report

March 27, 2021

Versions

2021-03-30 (2)
2021-03-27 (1)

A 44-year-old man was admitted to hospital to be performed re-thrombectomy after previously performed thrombectomy at the referring hospital but did not show clinical improvement. CT angiography results before re-thrombectomy showed a central thrombus measuring 1.1 cm in diameter, and an impression of 2.6 cm long at the branching of the right external Iliaca artery which caused total obstruction of the right illiaca external artery to the distal. Aortofemoral bypass graft surgery is a procedure utilized commonly for the treatment of aortoiliac occlusive disease. The treatment given to manage symptoms if medical management or minimally invasive therapy, such as balloon angioplasty and stenting, was unsuccessful or unsuitable for the patient. Aortofemoral bypass graft surgical procedure was performed on the patient. However, post procedure angiography showed no visible flow through the newly placed graft. A repair graft procedure was planned for the patient, but the patient refused to undergo further surgical procedures.

Budiarto, MD, R. M., & Hasan, M. R. D. (2021). Aorto Femoral Bypass Graft in Chronic Limb Ischemia Patient. Cardiovascular and Cardiometabolic Journal (CCJ), 2(1), 41–49. https://doi.org/10.20473/ccj.v2i1.2021.41-49

Download Citation

Conte M S, Pomposelli F B, Clair D G, Geraghty P J, McKinsey J F, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication J. Vasc. Surg. 2015.

Antoniou G A, Georgiadis G S, Antoniou S A, Makar R R, Smout J D and Torella F. Bypass surgery for chronic lower limb ischaemia Cochrane Database Syst. Rev. 2017.

Aboyans V, Ricco J B, Bartelink M L E L, Björck M, Brodmann M, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) Eur. Heart J. 2018.

Norgren L, Hiatt W R, Bell K, Nehler M R, Harris K A, Fowkes F G R, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur. J. Vasc. Endovasc. Surg. 2007.

Anon 2017 Correction. AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (Journal of the American J. Am. Coll. Cardiol. 2016.

Oresanya L, Zhao S, Gan S, Fries B E, Goodney P P, et al. Functional outcomes after lower extremity revascularization in nursing home residents: A national cohort study JAMA Intern. Med. 2015;175 951–7.

Kinlay S. US Department of Veterans Affairs Circ Cardiovasc Interv. 2017; 9: 1–23.

Todd D J, Kagan A, Chibnik L B and Kay J. Cutaneous changes of nephrogenic systemic fibrosis: Predictor of early mortality and association with gadolinium exposure Arthritis Rheum. 2007.; 56: 3433–41.

Thukkani A K, and Kinlay S. Endovascular Intervention for Peripheral Artery Disease Circ. Res. 2015.; 116: 1599–613.

AbuRahma A F, Hayes J D, Flaherty S K and Peery W. Primary iliac stenting versus transluminal angioplasty with selective stenting J. Vasc. Surg. 2007. 46.

Slovut D P, and Lipsitz E C. Surgical technique and peripheral artery disease Circulation. 2012; 126: 1127–38.

Rosenfield K, Jaff M R, White C J, Rocha-Singh K, Mena-Hurtado C, et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease N. Engl. J. Med. 2015;373: 145–53.

Krankenberg H, Tübler T, Ingwersen M, Schlüter M, Scheinert D, et al. Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: The randomized Femoral Artery In-Stent Restenosis (FAIR) trial Circulation. 2015; 132: 2230–6.

Sharma G, Scully R E, Shah S K, Madenci A L, Arnaoutakis D J, et al. Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease J. Vasc. Surg. 2018.

Ameli F M, Provan J L, Williamson C and Keuchler P M. Etiology and management of aorto-femoral bypass graft failure. J. Cardiovasc. Surg. (Torino). 1987.

Conte M S. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia J. Vasc. Surg. 2010;51: 69S-75S.

Li Z, Feng R, Qin F, Zhao Z, Yuan L, et al. Recanalization of native superficial femoral artery chronic total occlusion after failed femoropopliteal bypass in patients with critical limb ischemia J. Interv. Cardiol. 2018.

Taylor S M, Kalbaugh C A, Blackhurst D W, Hamontree S E, Cull D L, et al. Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: An analysis of 553 consecutive patients J. Vasc. Surg. 2005;42:227–34.

Mills J L, Conte M S, Armstrong D G, Pomposelli F B, Schanzer A and Sidawy A N. The Society for Vascular Surgery Lower Extremity Threatened Limb Classi fi cation System : Risk strati fi cation based on Wound , Ischemia , and foot Infection ( WIfI ) J. Vasc. Surg. 1982;59:220-234e2.